"I am humbled and honored to have the opportunity to work with such a great group of incredible people who see the potential in what we are building. I am excited to leverage their expertise, connections, and insight to enable us to accelerate our vision of removing the non-clinical barriers cancer patients face as they go through treatment."
Rahul Mahadevan, Founder and CEO of the WiTT Group, Inc.
Lori was the Vice President of Patient Advocacy and Diversity in Clinical Research at WCG. In her last corporate role, Lori was the Director of Diversity & Patient Engagement in R&D at Bristol-Myers Squibb (BMS). She built one of the first R&D diversity & clinical trial advocacy groups in pharma and focused on bringing awareness, accessibility, and the voice of the patient to clinical trials across multiple therapeutic areas. Moreover, her team concentrated on health disparities, and identified strategies for building relationships in minority communities. Her work has been recognized by Pharma Voice 100.
"I have spent the better part of my career seeking solutions to build health equity in clinical trials. While building awareness and accessibility to clinical trials is essential, equally important is providing the day-to-day help that people need to free them up to participate. Missing a few days of work during the month may not be prohibitive to participating in a clinical trial, if someone else can assist paying the rent, or babysitting, or buying food for the week. Unfortunately, in the real world there are additional pressures beyond being sick. I believe WiTT will relieve some of these concerns and thereby increase adherence in clinical trials."
Rich was most recently the CEO of Global Technology Partners, a FinTech company serving Africa. His prior roles included Head of Prepaid Products for Visa CEMEA based in Dubai UAE, and senior executive positions at Neiman Marcus, GE Capital and Ameritech. Rich brings decades of FinTech and digital payments expertise to WiTT.
"I am excited and proud of the WiTT mission and organization, and believe an innovative payments platform can help address the needs of the vulnerable and underserved patient populations, not only in the US, but globally as well. The opportunity enables me to leverage my global fintech expertise to enhance the healthcare impact that WiTT can have on cancer, and all chronic disease, patients both in the US and internationally."
Courtnay is the Chief Nursing Officer at Cedars-Sinai Marina Del Rey Hospital, and prior to that help similar leadership roles at Providence Health and Kaiser. She is a Nursing Executive with a successful track record of hospital operations and informatics related work. She is passionate about improving nursing workflows through technology and driving organizational goals towards innovative healthcare models.
"As nurses we constantly see patients who struggle to maintain to adhere to, or be compliant, with their treatment plans, because they do have the support they need once they are home. WiTT makes it incredibly easy for patients to leverage their friends, family, and the local community to support them as they go through treatment. What I love most is the simplicity of the platform, which is critical for patients who are dealing with cancer."
Dr. Clipper is a top healthcare influencer, nurse futurist, global speaker and podcast host. She was a successful chief nurse executive for over 20 years and was the first Vice President of Innovation at the American Nurses Association. She is a Fellow in the American Academy of Nursing, a Robert Wood Johnson Foundation Executive Nurse Fellow alumna, and ASU/AONL Executive Fellow in Health Innovation Leadership alumna. Dr. Clipper is the sole nurse member of the HIMSS Innovation Board of Advisors and is a start-up coach for MATTER international digital health accelerator.
"I am very excited to be a part of WiTT because it is a way to democratize healthcare and make care and wellness available to those who often are the most vulnerable. I believe the platform will generate some incredible SDoH data that nurses, case managers, nurse navigators, and social workers can use to impact adherence to treatment, thereby improving outcomes."
Heidi is a breast cancer patient and advocate who experienced her first cancer diagnosis as a mom of young children. The financial toxicity and emotional trauma experienced by her family far surpassed the physical challenges of treatments and surgeries. She is a sought-after key opinion leader and influencer with 15+ years of experience in healthcare advocacy and breast cancer activism.
She has served as the "voice of the patient" for myriad organizations including Ford, Google, the US Department of Defense, the American Cancer Society and Susan G Komen. Her experience has helped to establish and strengthen relationships with patient advocacy organizations that support patients and their families, and educate corporations on compassionate outreach to the worldwide cancer community. Her written work has been featured in Forbes, Huffington Post, CNN and The NY Times.
"I wish I had had a platform like WiTT when I was in the midst of my treatment. It would have made a profound and lasting impact for me and my entire family. I cannot wait to leverage my expertise to ensure every patient knows about WiTT as I believe it will change the lives of all cancer patients."
Matt spent over 20 years as the Senior Managing Director and Chief Venture Investment Officer at Ascension Ventures where his team was responsible for deploying $1+ billion in capital across 5 funds from 19 not-for-profit health system partners with a unique engagement / governance model. He turned Ascension Ventures from an idea into an industry leading platform and continues to advise entrepreneurs and companies trying to fix healthcare's big problems.
"For too long we have been talking about putting the patient in the center of their healthcare. WiTT is the first company I have come across that is actually doing that by helping solve patient's non-clinical needs in a unique way. I am excited to be part of their advisory team and leverage my network to help them address a critical gap in care that I believe will help health systems, health plans, and most importantly, patients."
Kolleen has extensive experience in global healthcare and medical technology markets with areas of expertise that include strategy development, portfolio innovation, multi-billion dollar P&L management as well as corporate governance and stewardship. She retired from Varian Medical Systems in December 2021 after 24 years, holding numerous executive roles including President of Oncology Systems, Proton Solutions and Chief Growth Officer. She currently sits on a variety of non-profit and for-profit boards.
"I am incredibly excited by the vision of WiTT to enable patients in need to successfully overcome the multitude of obstacles faced in traversing their healthcare journey. The support provided by WiTT is a catalyst for improved treatment compliance, extending caregiver capacity and bringing hope to those patients who might not otherwise have access or the resources to obtain care."
Deepak is an experienced Board Member and Medical Device Executive with a demonstrated history of working in the hospital & health care industry. He is the current SVP & Chief Medical Officer at Varian Medical Systems, a Siemens Healthineers company, and is a practicing oncologist. His Residency was focused in Radiation Oncology from Cleveland Clinic Foundation.
"There are many reasons why I am so honored to be part of the advisory team, but the most important to me is that WiTT has the ability to help patients going through treatment address some of the day-to-day burdens that could prevent patients from making their appointments. In many cases, its critical for cancer patients to make it to their appointments when scheduled; if not, this could adversely impact our ability to cure a cancer. WiTT has the ability to impact outcomes as much as therapy itself!"
Craig is an advisor to technology and biopharmaceutical companies, leading universities, and the venture community, bringing vision and driving action at the intersection of research, digital solutions, and patient engagement. Craig was the Head of Clinical Innovation and Venture Partner at Pfizer, and currently serves on the Board of Directors for the Decentralized Trials & Research Alliance (Co-Chair), Foundation for Sarcoidosis Research and the MedStar Health Research Institute, and, as well as on the Editorial Board for Therapeutic Innovation & Regulatory Science. He has been recognized among Pharmaceutical Executive's Emerging Leaders, CenterWatch Top 20 Innovators in Clinical Trials, the Medicine Maker Power List and the AlleyWatch Who's Who in eHealth.
"Diversity and representation in clinical trials is a priority for research sponsors and an expectation among regulators, but making research accessible for all will require smart approaches to addressing the non-clinical needs of patients. WiTT is uniquely positioned to drive innovative partnerships to address these needs so that patients can focus on the treatment and research options right for them."
Lisa is the Director of Philanthropic Services at Force Family Office and has been involved in the non-profit and philanthropic world with various foundations. She is sought after as an advocate and influencer for organizations focusing on Impact Investing.
"From the moment I was first introduced to WiTT, it grabbed me by the heart and never let go. Going through a serious illness is incredibly hard on both the patient and the people who love them. WiTT provides a simple solution for people to support the patient they care about with exactly what that patient needs most, when they need it, and an easy way for that patient to ask for help without feeling like a burden. I believe the platform creates an opportunity for organizations to leave a legacy and have a significant social impact."
Carla is the CEO of Family Reach, a national non-profit leading the charge to remove financial barriers that stand between a cancer patient and their treatment. She is a Cancer survivor, patient advocate, and a spirited leader who has been leading the charge to making tangible impacts for cancer patients and their families through innovative solutions and collaboration.
As CEO of Family Reach for the past 15 years, she has seen first-hand the devastating effect a cancer diagnosis has on a family's finances. Her knowledge about this overlooked, yet vast, reality of cancer has made her a sought-after speaker across the U.S. Under her leadership, Family Reach increased its hospital network from 3 east coast sites to more than 850 top-tier hospitals and cancer centers nationwide.
"I believe in the WiTT platform and the thoughtful way it allows families to create a registry of tangible and immediate needs. It offers people who care about someone battling cancer an opportunity to support them in a way they know is needed, and it empowers the patient to state exactly what they need at that moment. WiTT bridges the gap between a patient and the deeply caring community that surrounds them. We have been excited to work with the WiTT team over the past year to use technology to positively support the families we serve."